Back to Journals » Open Access Journal of Clinical Trials » Volume 2

Activities of key glycolytic enzymes in the plasma of Saudi autistic patients

Authors El-Ansary A, Al-Daihan S, Al-Dabas A, Al-Ayadhi L

Published 13 April 2010 Volume 2010:2 Pages 49—57


Review by Single-blind

Peer reviewer comments 2

A El-Ansary1, S Al-Daihan1, A Al-Dabas1, L Al-Ayadhi2

1Biochemistry Department, Science College, 2Autism Research and Treatment Unit, Department of Physiology, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia

Objective: Measurement of plasma levels of lactate, lactate oxidase (LOX), pyruvate kinase (PK), and hexokinase (HK) as possible glycolytic parameters to assess brain damage in autistic patients.

Design and methods: Plasmatic levels of lactate, LOX, PK, and HK were determined in 20 autistic children aged 3–15 years and 20 age-matching healthy control subjects.

Results: Plasmatic levels of lactate and LOX were significantly higher in autistic patients compared to healthy subjects and that of PK and HK were significantly lower in these patients as compared to controls. This could reflect the impaired metabolism of astrocytes, the brain cells responsible for the production and provision of lactate, as the primary metabolic fuel for neurons.

Conclusion: Remarkably different levels of plasma glycolytic parameters were recorded in Saudi autistic patients. This could be correlated to the impairment of energy metabolism, glutathione depletion, and lead intoxication previously detected in the same investigated samples. The identification of biochemical markers related to autism would be advantageous for earlier clinical diagnosis and intervention.
Keywords: autism, glycolysis, lactate, lactate oxidase, pyruvate kinase, hexokinase

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

Nanoparticles as biochemical sensors

Afaf El-Ansary, Layla M Faddah

Nanotechnology, Science and Applications 2010, 3:65-76

Published Date: 23 September 2010

Biomarker discovery in neurological diseases: a metabolomic approach

Afaf El-Ansary, Nouf Al-Afaleg, Yousra Al-Yafaee

Open Access Journal of Clinical Trials 2009, 1:27-41

Published Date: 1 December 2009

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010